Skip to main content
. 2015 Apr 9;26(7):1459–1464. doi: 10.1093/annonc/mdv171

Table 2.

Outcomes and estimates of the probability of dose-limiting toxicity at each study dose level

Dose level Cixutumumab weekly dose (mg/kg) Prior estimate for DLT (%) Patients treated Patients with DLT (s) Posterior estimate for DLT (%) 95% Bayesian credible interval (%)
A 1 10 4 0 4.5 1.0–14.1
B 3 13 13 1 6.2 1.6–17.8
C 6 18 12 1 9.4 2.7–23.6